Tag: pharmaceuticals
-

Precision Gene-Editing Biotech Gains $200M in New Funds
A biotechnology company says it discovers therapies with the gene-editing technique Crispr to carry out a wider range of precise genomic corrections.
-

Neuro Disease Start-Up Raises $73M in Early Funds
A new enterprise discovering treatments for neurodegenerative diseases is merging with another start-up and raising $73 million its first venture round.
-

Trial Underway Testing Suicide-Prevention Nasal Spray
A clinical trial testing a nasal spray against a placebo to prevent suicide from depression enrolled its first participants considered at high risk of suicide.
-

GSK, Biotech Partner on Neuro Antibodies in $2.2B Deal
GlaxoSmithKline and biotechnology company Alector Inc. agreed to co-develop two synthetic antibodies for treating neurodegenerative disorders.
-

Microbiome Drug Candidate Licensed in $525M Deal
A therapy designed to regenerate healthy gut microbes for treating dangerous intestinal infections is licensed for commercialization to Nestlé Health Science.
-

Covid-19 Nasal Spray Vaccine Discontinued
A biotechnology company is discontinuing further work on a Covid-19 vaccine nasal spray after clinical trial results show it produces little immune response.
-

Trial Shows In-Body Crispr Therapy Feasibility
Early clinical trial data show gene editing with Crispr performed inside the body can correct an inherited neurological condition, with few adverse effects.
-

Long-Acting Capsule Helps Reduce Opioid Use
A capsule designed to take once a week is shown in animal tests to continuously deliver a craving-reduction drug in that time and suppress opioid intake.
-

Biotechs Partner on Lower Cost AI-Designed Drugs
Two biotechnology companies are collaborating on discovery and development of new drugs designed with artificial intelligence, at lower cost to patients.
-

Micro Brain Robot Granted Orphan Status
A tiny remote-controlled device that carries chemotherapy drugs to brain tumors received orphan drug status from the Food and Drug Administration.